Phase 3 Chondral Defect Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
Chondral DefectArticular Cartilage Defect
Vericel Corporation309 enrolled4 locationsNCT06915233
Recruiting
Phase 3
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Chondral DefectOsteochondritis Dissecans (OCD)Articular Cartilage Defect+1 more
Vericel Corporation45 enrolled12 locationsNCT03588975
Recruiting
Phase 3
Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
Chondral DefectBone Marrow Aspirate ConcentrateAcetabular Labrum Tear+1 more
Massachusetts General Hospital160 enrolled1 locationNCT06003101
Completed
Phase 2Phase 3
Platelet rich plasma injection for treatment of osteoarthritis
osteochondral defect
Kade Paterson30 enrolled1 locationACTRN12611000651987
Withdrawn
Phase 2Phase 3
Adipose-derived stem cells in patients with knee osetoarthritis: A randomised controlled trial evaluating pain, function and cartillage repair
stem cell researchosteochondral defect
Kade Paterson60 enrolled1 locationACTRN12611000274976